Thursday, May 30, 2013
Scynexis Regains Rights to Antifungal Compound
Durham company Scynexis has nabbed development and commercialization rights for an antifungal platform that it previously sold to Merck in 2002.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment